Recovery Resources & Insights

Addiction Information

The Opioid Crisis in San Francisco: What Local Families Need to Know

By Dr. Aaron Vasquez, Medical Director - Published February 2026 - 9 min read

San Francisco recorded more than 800 accidental overdose deaths in 2023, the great majority involving fentanyl. That number is roughly twice the homicide rate for the city in the same year, and it has shaped how every emergency department, primary care clinic, and addiction treatment center in the Bay Area now thinks about opioid use. At NCL Rehab, our admissions intake data mirrors the county data: nearly one in three patients arriving for "opioid use" turns out, on toxicology, to have been using fentanyl - often in pills they believed were oxycodone, Xanax, or Adderall purchased through informal channels.

For families in San Francisco, this changes the practical risk calculus. The conversation a parent or partner used to have - "are you using drugs?" - now has to include a conversation about drug supply. A young person taking what they believe to be a single Percocet at a party can encounter a fatal dose of fentanyl in that one pill. There is no slow slide, no warning sign, no history of use required. The escalation curve from first use to overdose risk is no longer measured in months or years; it is measured in weeks or, in some cases, a single dose.

Three protective actions matter for San Francisco families right now. First, naloxone (Narcan) should be in every household where anyone uses any substance recreationally. It is available without a prescription at every CVS and Walgreens, and free through the San Francisco AIDS Foundation harm-reduction sites. Second, fentanyl test strips are legal, cheap, and available through the SF Department of Public Health. Third, if a family member shows signs of substance use, an admissions conversation sooner rather than later is the clinically honest move. Call (209) 414-5556.

Recovery Tips

Veterans and Addiction: Why Service Members Need Specialized Care in San Francisco

By Linnea Park, PsyD, Clinical Director - Published December 2025 - 8 min read

The clinical research on veteran populations is consistent: substance use disorder co-occurs with PTSD, traumatic brain injury, and chronic pain at rates substantially higher than in the general population. Department of Veterans Affairs data suggests that roughly 11 percent of OEF/OIF veterans meet criteria for a substance use disorder, and the rate climbs sharply when comorbid PTSD is present. The San Francisco Bay Area is home to a large veteran population, much of it served by the VA Palo Alto and SF VA systems - which provide excellent care, but often have wait times that the clinical urgency does not allow.

What veterans need clinically that general residential treatment rarely provides: trauma-focused work that understands operational and combat trauma rather than treating it as generic PTSD; staff who can navigate VA benefits and Tricare without forcing the veteran to do that work themselves; peer cohorts that include other veterans, where the language and reference points are shared without explanation; and a clinical relationship with the patient as a competent adult who has seen things, not as a patient to be managed.

NCL Rehab accepts Tricare and works directly with VA case managers on community-care referrals. Our first-responder and veteran tracks are clinically integrated - run by Linnea Park and a team with subspecialty training in occupational and combat trauma. The peer cohort structure groups veterans together for the first two weeks before integrating into the broader residential population. If you are a veteran, a veteran family member, or a clinician looking to refer, call our admissions line and ask for the veteran intake protocol.

Recovery Tips

When Loss Meets Sobriety: Grieving Without a Drink in Your Hand

By the NCL Clinical Team - Published October 2025 - 7 min read

One of the most common questions our outpatient clinicians hear in the first year of sobriety is some version of: "How am I supposed to get through this without using?" The "this" varies - the death of a parent, a divorce, the end of a long career, the loss of a child. Grief is one of the highest-risk relapse triggers in early recovery, and it is also one of the least talked about in addiction treatment marketing. We want to talk about it directly.

Substance use, for many of the patients who come to NCL, has functioned for years as a way of regulating overwhelming feeling. Grief, by its nature, is feeling that does not respond to the usual regulation strategies - including the pharmacological one that the substance provided. Sobriety in the middle of grief means encountering the loss without the buffer that has been there for years. That is a clinically real challenge, and pretending otherwise is a disservice.

What works, drawn from both the grief and addiction literature: structured social support specifically calibrated to the grieving period (alumni group attendance, sponsor contact, family-systems sessions); psychiatric review of any medication regimen, because grief can mimic and intensify depressive symptoms; physical regulation practices (sleep protection, somatic work, the meditation garden and acupuncture suite, for residents); and a clinical conversation about what the substance was specifically doing in moments of distress, so that alternative regulation strategies can be built deliberately. Loss in early recovery does not have to be the trigger for relapse. It does have to be treated as a clinical priority - call (209) 414-5556 if you are navigating it now.